zabdeno
janssen-cilag international n.v. - recombinant adenovirus type 26 (ad26) encoding the glycoprotein (gp) of the ebola virus zaire (zebov) mayinga strain - febra hemoragica ebola - vaccinuri - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
mvabea
janssen-cilag international n.v. - recombinant modified vaccinia ankara bavarian nordic virus encoding the: ebola virus zaire (zebov) mayinga strain glycoprotein (gp); ebola virus sudan gulu strain gp; ebola virus taï forest strain nucleoprotein and the marburg virus musoke strain gp - febra hemoragica ebola - vaccinuri - active immunization for prevention of disease caused by ebola virus (zaire ebolavirus species) in individuals ≥ 1 year of age.
rybrevant
janssen-cilag international n.v. - amivantamab - carcinom, pulmonar non-celulă mică - agenți antineoplazici - rybrevant as monotherapy is indicated for treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (nsclc) with activating epidermal growth factor receptor (egfr) exon 20 insertion mutations, after failure of platinum-based chemotherapy.
uptravi 200 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 200 mcg
uptravi 400 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 400 mcg
uptravi 600 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 600 mcg
uptravi 1000 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1000 mcg
uptravi 1200 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1200 mcg
uptravi 1400 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1400 mcg
uptravi 1600 mcg comprimate filmate
janssen-cilag international nv - selexipagum - comprimate filmate - 1600 mcg